Compound Detail
CHEMBL633
AMIODARONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL633 |
| Name | AMIODARONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IYIKLHRQXLHMJQ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
69
Targets
139
Activities
3
Assay Types
29
PK Parameters
20
Publications
2
Known Names
18
Indications
Molecular Properties
645.3
MW (Da)
6.94
ALogP
4
HBA
0
HBD
42.7
PSA (Ų)
0.17
QED
2
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1985 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Arrhythmias, Cardiac Arrhythmias, Cardiac Atrial Fibrillation Atrial Flutter Cardiomyopathies Death, Sudden, Cardiac Heart Arrest Heart Diseases Heart Failure Heart Failure Myocardial Infarction Tachycardia, Ventricular Ventricular Fibrillation Amyloidosis, Familial Hemorrhagic Fever, Ebola Severe Acute Respiratory Syndrome Tachycardia, Supraventricular Coronary Disease
ATC Classification
C01BD01
amiodarone
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
IC50 80 meas. best 7.52
Ki 52 meas. best 9.0
EC50 7 meas. best 6.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 9.0 | 8.195 | 1.0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase CHEMBL4931 | Ki | 7.6 | 7.6 | 25.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 7.52 | 5.704 | 30.0 | 5 |
| Unchecked CHEMBL612545 | Ki | 7.32 | 6.535 | 48.0 | 6 |
| Unchecked CHEMBL612545 | IC50 | 7.27 | 6.03 | 54.0 | 8 |
| C-8 sterol isomerase ERG2 CHEMBL3224 | Ki | 7.21 | 7.21 | 62.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 7.01 | 7.01 | 97.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.93 | 6.93 | 117.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 6.67 | 6.67 | 212.0 | 1 |
| Voltage-gated L-type calcium channel CHEMBL2095229 | IC50 | 6.57 | 6.145 | 270.0 | 2 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 6.51 | 6.51 | 312.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 6.39 | 6.39 | 404.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 6.39 | 6.39 | 410.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 6.3 | 6.3 | 506.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.23 | 6.23 | 587.0 | 1 |
| Thyroid hormone receptor beta CHEMBL1947 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 6.2 | 6.2 | 629.0 | 1 |
| Thyroid hormone receptor alpha CHEMBL1860 | IC50 | 6.19 | 6.19 | 650.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 6.17 | 6.17 | 679.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | EC50 | 6.1 | 6.1 | 800.0 | 1 |
| Tyrosine-protein kinase Fyn CHEMBL1841 | IC50 | 6.09 | 6.09 | 817.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 6.04 | 6.04 | 923.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 5.99 | 5.99 | 1026.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 5.97 | 5.97 | 1077.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 5.92 | 5.92 | 1208.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 5.91 | 5.91 | 1224.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 5.82 | 5.82 | 1499.0 | 1 |
| Cytochrome P450 2C8 CHEMBL3721 | Ki | 5.82 | 5.055 | 1500.0 | 2 |
| Solute carrier organic anion transporter family member 1A4 CHEMBL1781860 | Ki | 5.75 | 5.75 | 1800.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 5.74 | 5.74 | 1806.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 5.7 | 5.7 | 1990.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL2573 | Ki | 5.68 | 5.68 | 2100.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 5.65 | 5.65 | 2252.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 5.64 | 5.64 | 2271.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 5.64 | 5.64 | 2305.0 | 1 |
| CHRC5 cell line CHEMBL614457 | EC50 | 5.64 | 5.64 | 2300.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 5.6 | 5.6 | 2505.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.6 | 5.6 | 2500.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 5.58 | 5.58 | 2613.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.57 | 5.31 | 2700.0 | 2 |
| Delta-type opioid receptor CHEMBL236 | Ki | 5.55 | 5.55 | 2825.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 5.5 | 5.5 | 3201.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | Ki | 5.5 | 5.37 | 3200.0 | 2 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial CHEMBL4461 | EC50 | 5.49 | 5.49 | 3250.0 | 1 |
| Lethal factor CHEMBL4372 | IC50 | 5.46 | 5.46 | 3500.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 5.45 | 5.45 | 3590.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 5.44 | 5.44 | 3630.0 | 1 |
| C-C chemokine receptor type 2 CHEMBL4015 | Ki | 5.37 | 5.37 | 4285.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 5.34 | 5.34 | 4571.0 | 1 |
| Sodium channel alpha subunit CHEMBL2331043 | IC50 | 5.32 | 5.32 | 4800.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 21121.32 | ng.hr.mL-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.7 | mL.min-1.kg-1 | Macaca |
| CL | 14.7 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 14.7 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 11.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 27.0 | mL.min-1.g-1 | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| F | 50.0 | % | Homo sapiens |
| Fu | 0.0002 | - | - |
| Fu | 1e-06 | - | - |
| Fu | 0.0002 | - | Homo sapiens |
| Fu | 0.0002 | - | Homo sapiens |
| Fu | 0.0002 | - | Homo sapiens |
| Fu | 0.0001 | - | Homo sapiens |
| Fu | 0.0012 | - | Canis lupus familiaris |
| MRT | 620.0 | hr | Homo sapiens |
| T1/2 | 820.0 | hr | Homo sapiens |
| T1/2 | 720.0 | hr | Homo sapiens |
| T1/2 | 35.0 | hr | Homo sapiens |
| T1/2 | 4.0 | hr | Homo sapiens |
| T1/2 | 17.0 | hr | Homo sapiens |
| Tmax | 7.3 | hr | Homo sapiens |
| Vd | 0.9 | L.kg-1 | Oryctolagus cuniculus |
| Vd | 148.0 | L.kg-1 | Oryctolagus cuniculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1437 |
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 224 |
| 11806713 | 10.1021/jm001126+ | Rattus norvegicus | 27 |
| 17228875 | 10.1021/jm060878m | Heart | 20 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 18024584 | 10.1073/pnas.0709695104 | H4 | 13 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 20509610 | 10.1021/jm100298d | Molecular identity unknown | 10 |
| 20509610 | 10.1021/jm100298d | NON-PROTEIN TARGET | 9 |
| 7286032 | 10.1007/bf00562807 | Homo sapiens | 9 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 16621936 | 10.1124/dmd.105.006619 | ADMET | 8 |
| 25544686 | 10.1016/j.ejmech.2014.12.028 | HepG2 | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 22328583 | 10.1124/dmd.111.043505 | Cytochrome P450 2J2 | 7 |
| 16451055 | 10.1021/jm050691f | Trypanosoma cruzi | 6 |
| 11806713 | 10.1021/jm001126+ | CHO-K1 | 5 |
| 20509610 | 10.1021/jm100298d | Heart | 5 |
| 12061889 | 10.1021/jm0200409 | ADMET | 5 |
Data from ChEMBL 36 via Core Engine